Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 27 Mar 2023 for Elevance Health, Inc., €244k. Read the official filing
Filing timeline
BuySaleGloria M. Mccarthy
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gloria M. Mccarthy: trading record in brief
All filings by Gloria M. Mccarthy on record concern Elevance Health, Inc., in the capacity of chief executive. Over a trading history stretching from 1 March 2022 to 24 March 2023, the count stands at 3 filings.
Every open-market trade on record is a sale: 1 sale worth €244k. Outside the open market, there are 2 share grants. Since January 2023: no purchases and 1 sale on the market.
The newest entry dates from 27 March 2023: an open-market sale of €244k, in Elevance Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gloria M. Mccarthy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
600 shares@ US$440.7847.1% of flowCommon StockSEC:0001156039-23-000037:0
617 shares@ US$469.0352.9% of flowCommon StockSEC:0001156039-23-000028:0
4,871 shares@ US$451.50100.0% of flowCommon StockSEC:0001156039-22-000023:0
3 of 3 declarations
